Search

everythinglearnresearchcommunity

for

Search:↓

BTNL2 helps protect hair follicles from immune attacks, which could aid in treating alopecia areata.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Dual TCR Treg cells are common in mouse tissues and vary by location.

CD1d expression in scalp skin and hair follicles changes with the hair cycle and may help protect against microbes.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

CD34 marks potential stem cells in dog hair follicles.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

CD2 might be a new treatment target for patchy alopecia areata.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

CD4 is crucial for maintaining skin stem cell balance and aiding wound healing.

Enhancing Tregs can protect against alopecia areata.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.